Cited by 328Cannabis and Cannabinoid ResearchReceptor Mechanisms and SignalingNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis

Open access

Rios, Carl, Gomes, Ivone, Devi, Lakshmi A·2006·British Journal of Pharmacology

DOI 10.1038/sj.bjp.0706757PMC PMC1751792

Open this paper in CoChat — free account Open PDF

Abstract

Several studies have described functional interactions between opioid and cannabinoid receptors; the underlying mechanism(s) have not been well explored. One possible mechanism is direct receptor–receptor interactions, as has been demonstrated for a number of G‐protein‐coupled receptors. In order to investigate interactions between opioid and cannabinoid receptors, we epitope tagged μ, δ and κ opioid receptors with Renilla luciferase and CB1 cannabinoid or CCR5 chemokine receptors with yellow fluorescent protein and examined the extent of substrate hydrolysis induced bioluminescence resonance energy transfer (BRET) signal. We find that coexpression of opioid receptors with cannabinoid receptors, but not with chemokine receptors, leads to a significant increase in the level of BRET signal, suggesting that the opioid–cannabinoid interactions are receptor specific. In order to examine the implications of these interactions to signaling, we used GTP γ S binding and mitogen‐activated protein kinase (MAPK) phosphorylation assays and examined the effect of receptor activation on signaling. We find that the μ receptor‐mediated signaling is attenuated by the CB1 receptor agonist; this effect is reciprocal and is seen in heterologous cells and endogenous tissue expressing both receptors. In order to explore the physiological consequences of this interaction, we examined the effect of receptor activation on the extent of Src and STAT3 phosphorylation and neuritogenesis in Neuro‐2A cells. We find that the simultaneous activation of μ opioid and CB1 cannabinoid receptors leads to a significant attenuation of the response seen upon activation of individual receptors, implicating a role for receptor–receptor interactions in modulating neuritogenesis. British Journal of Pharmacology (2006) 148, 387–395. doi:10.1038/sj.bjp.0706757

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0706757

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,618
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
KUNISHIMA, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Jingami, H., & Morikawa, K. (2000) · Nature · doi:10.1038/35039564 · Cited by 1,249
Heterodimerization is required for the formation of a functional GABAB receptor
White, J. H. M., Wise, A., Main, M. J., Green, A., Fraser, N. J., Disney, G. H., Barnes, A. A., Emson, P. C., Foord, S. M., & Marshall, F. H. (1998) · Nature · doi:10.1038/25354 · Cited by 1,165
International Union of Pharmacology. XII. Classification of opioid receptors
Bn, D., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P. B., Portoghese, P. S., & Hamon, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06958-3 · Cited by 732
Dimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function
Angers, S., Salahpour, A., & Bouvier, M. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091701.082314 · Cited by 586
Pharmacological and biochemical interactions between opioids and cannabinoids
Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 391
A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
Gomes, I., Gupta, A., Filipovska, J., Szeto, H. H., Pintar, J. E., & Devi, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307601101 · Cited by 386
Self-citation
Ultrastructural Localization of the CB1 Cannabinoid Receptor in μ-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus
Rodriguez, J. J., Mackie, K., & Pickel, V. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00823.2001 · Cited by 372
Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation
Jordan, B. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011384898 · Cited by 328

Flagged first, then by citations

Show all 42 references

Sorted by citations

Items 201–300 of 328

Acute and Chronic Mu Opioids Differentially Regulate Thrombospondins 1 and 2 Isoforms in Astrocytes
Phamduong, E., Rathore, M. K., Crews, N. R., D’Angelo, A. S., Leinweber, A. L., Kappera, P., Krenning, T. M., Rendell, V. R., Belcheva, M. M., & Coscia, C. J. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400172n · Cited by 18
Preimplantation Mouse Embryo Is a Target for Opioid Ligand-Receptor Signaling1
Chen, Y., Kong, S., Tang, X., Fu, Y., Wang, B. J., Zhang, S., & Wang, H. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.118083 · Cited by 16
GGIP: Structure and sequence-based GPCR-GPCR interaction pair predictor
Nemoto, W., Yamanishi, Y., Limviphuvadh, V., Saito, A., & Toh, H. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25071 · Cited by 16
Distinctions among GABAA and GABAB responses revealed by calcium channel antagonists, cannabinoids, opioids, and synaptic plasticity in rat hippocampus
Lafourcade, C. A., & Alger, B. E. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1040-4 · Cited by 15
The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome
Sałaga, M., Binienda, A., Tichkule, R. B., Thakur, G. A., Makriyannis, A., Storr, M., & Fichna, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.016 · Cited by 15
Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay
Zhou, H., Peng, X., Hou, T., Zhao, N., Qiu, M., Zhang, X., & Liang, X. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112218 · Cited by 16
Antinociceptive and sedative activity of Vernonia patula and predictive interactions of its phenolic compounds with the cannabinoid type 1 receptor
Siraj, M. A., Howlader, M. S. I., Rahaman, M. S., Shilpi, J. A., & Seidel, V. (2020) · Phytotherapy Research · doi:10.1002/ptr.6876 · Cited by 14
Interactions between cannabinoid and opioid receptors in a mouse model of diabetic neuropathy
Toniolo, E. F., Gupta, A., Franciosi, A. C., Gomes, I., Devi, L. A., & Dale, C. S. (2021) · Pain · doi:10.1097/j.pain.0000000000002527 · Cited by 15
Self-citation
Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function
Gomes, I., Gupta, A., Bushlin, I., & Devi, L. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00268 · Cited by 14
Self-citation
Discriminative Stimulus Effects of Hallucinogenic Drugs: a Possible Relation to Reinforcing and Aversive Effects
Mori, T., Yoshizawa, K., Shibasaki, M., & Suzuki, T. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12r08cp · Cited by 14
Hemorphins Act as Homeostatic Agents in Response to Endotoxin-Induced Stress
Barkhudaryan, N., Zakaryan, H., Sarukhanyan, F. P., Gabrielyan, A., Dosch, D., Kellermann, J., & Lottspeich, F. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0097-3 · Cited by 14
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders
Kumar, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010152 · Cited by 15
G-Protein-Coupled Heteromers
Gomes, I., Gupta, A., & Devi, L. A. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391862-8.00012-0 · Cited by 13
Self-citation
Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors
Bartuzi, D., Kaczor, A. A., & Matosiuk, D. (2017) · Molecules · doi:10.3390/molecules22071188 · Cited by 13
Role of Antibodies in Developing Drugs That Target G‐Protein‐Coupled Receptor Dimers
Hipser, C., Bushlin, I., Gupta, A., Gomes, I., & Devi, L. A. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20199 · Cited by 13
Self-citation
Peripherally restricted cannabinoid and mu-opioid receptor agonists synergistically attenuate neuropathic mechanical hypersensitivity in mice
Limerick, G., Uniyal, A., Ford, N. C., He, S.-Q., Grenald, S. A., Zhang, C., Cui, X., Sivanesan, E., Dong, X., Guan, Y., et al. (2024) · Pain · doi:10.1097/j.pain.0000000000003278 · Cited by 13
Involvement of opioid system in cognitive deficits induced by ∆9-tetrahydrocannabinol in rats
Egashira, N., Manome, N., Mishima, K., Iwasaki, K., Oishi, R., & Fujiwara, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2442-x · Cited by 12
Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice
Chopda, G. R., Parge, V., Thakur, G. A., Gatley, S. J., Makriyannis, A., & Paronis, C. A. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232132 · Cited by 11
Modulation by Neuropeptide FF of the interaction of Mu-opioid (MOP) receptor with G-proteins
Kersanté, F., Moulédous, L., Zajac, J., & Mollereau, C. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.02.014 · Cited by 11
Pharmacological Profiles of Oligomerized μ-Opioid Receptors
Lee, C. W., & Ho, I.-K. (2013) · Cells · doi:10.3390/cells2040689 · Cited by 11
Unveiling the link between chronic pain and misuse of opioids and cannabis
Dagher, M., Alayoubi, M., Sigal, G. H., & Cahill, C. M. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02765-3 · Cited by 11
Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the science
Breault, É., Desgagné, M., Neve, J. D., Côté, J., Barlow, T. M. A., Ballet, S., & Sarret, P. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107408 · Cited by 10
Revisiting CB1 cannabinoid receptor detection and the exploration of its interacting partners
Esteban, P. F., García‐Ovejero, D., Paniagua‐Torija, B., Moreno‐Luna, R., Arredondo, L. F., Zimmer, A., Arévalo‐Martín, Á., & Molina‐Holgado, E. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108680 · Cited by 10
Genetic network regulating visual acuity makes limited contribution to visually guided eye emmetropization
Tkatchenko, T. V., & Tkatchenko, A. V. (2021) · Genomics · doi:10.1016/j.ygeno.2021.06.021 · Cited by 10
Experimental Strategies for Studying G Protein-Coupled Receptor Homo- and Heteromerization with Radioligand Binding and Signal Transduction Methods
Maggio, R., Rocchi, C., & Scarselli, M. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391862-8.00016-8 · Cited by 10
Cannabinoid receptor modulation changes the accumbal neuronal responses to morphine in the reinstatement of morphine‐induced conditioned place preference
Khaleghzadeh‐Ahangar, H., & Haghparast, A. (2019) · Addiction Biology · doi:10.1111/adb.12817 · Cited by 10
The Endocannabinoid System in Prefrontal Synaptopathies
Scheyer, A. F., Martin, H. G. S., & Manzoni, O. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_7 · Cited by 10
Quantal size increase induced by the endocannabinoid 2‐arachidonoylglycerol requires activation of CGRP receptors in mouse motor synapses
Tarasova, E., Bogacheva, P. O., Chernyshev, K., & Balezina, O. P. (2023) · Synapse · doi:10.1002/syn.22281 · Cited by 9
Opioid Receptor Dimerization
Rozenfeld, R., Gomes, I., & Devi, L. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_15 · Cited by 9
Self-citation
Potential therapeutic targets for the treatment of opioid abuse and pain
Kiguchi, N., & Ko, M. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.09.002 · Cited by 9
Dual Role of the Spinal Endocannabinoid System in Response to Noxious Stimuli: Antinociceptive Pathways and Neuropathic Pain Mechanisms
Saldaña, R., Carrascosa, A. J., Torregrosa, A. B., Navarrete, F., García‐Gutiérrez, M. S., & Manzanares, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110692 · Cited by 8
SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function
Durydivka, O., Mackie, K., & Blahoš, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1213094 · Cited by 9
Divergent Response to Cannabinoid Receptor Stimulation in High and Low Stress-Induced Analgesia Mouse Lines Is Associated with Differential G-Protein Activation
Leśniak, A., Chmielewska, D., Poznański, P., Bujalska‐Zadrożny, M., Strzemecka, J., & Sacharczuk, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.02.015 · Cited by 8
Receptor and Channel Heteromers as Pain Targets
Berg, K. A., Patwardhan, A. M., & Akopian, A. N. (2012) · Pharmaceuticals · doi:10.3390/ph5030249 · Cited by 8
∆9-Tetrahydrocannabinol Decreases NOP Receptor Density and mRNA Levels in Human SH-SY5Y Cells
Cannarsa, R., Carretta, D., Lattanzio, F., Candeletti, S., & Romualdi, P. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9552-0 · Cited by 8
Treatment of acute cannabinoid overdose with naloxone infusion
Richards, J. R., Schandera, V., & Elder, J. W. (2017) · Toxicology Communications · doi:10.1080/24734306.2017.1392715 · Cited by 8
Genetic contributions to Type 2 diabetes: recent insights
Sale, M. M., & Rich, S. S. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.2.207 · Cited by 8
Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach
Hovah, M. E. L., & Holzgrabe, U. (2024) · Medicinal Research Reviews · doi:10.1002/med.22050 · Cited by 7
Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphine
Pearl‐Dowler, L., Posa, L., López-Canul, M., Teggin, A., & Gobbi, G. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110805 · Cited by 7
Effects of dronabinol on morphine‐induced dopamine‐related behavioral effects in animals
Mori, T., Shibasaki, M., Abe, M., Udagawa, Y., & Suzuki, T. (2012) · Synapse · doi:10.1002/syn.21586 · Cited by 7
Advancements in drug development for diarrhea-predominant irritable bowel syndrome
Dothel, G., Barbaro, M. R., Raschi, E., Barbara, G., & Ponti, F. D. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1442434 · Cited by 7
CB1 Cannabinoid Receptors: Molecular Biology, Second Messenger Coupling and Polarized Trafficking in Neurons
Irving, A. J., McDonald, N. A., & Harkany, T. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_5 · Cited by 7
Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
James, J. C., Thrush, J. R., Yusufali, T. M., Shaw, H. E., Avram, M., Moran, J. H., & Fantegrossi, W. E. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112672 · Cited by 6
Cross-Talk of Toll-Like Receptor 5 and Mu-Opioid Receptor Attenuates Chronic Constriction Injury-Induced Mechanical Hyperalgesia through a Protein Kinase C Alpha-Dependent Signaling
Chang, C. Y., Liu, H.-K., Yeh, C., Yang, M.-L., Liao, W., Liu, C., & Tseng, T.-J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041891 · Cited by 6
Effects of the cannabinoid CB1-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male rats
Alkhelb, D. A., Kirunda, A., Ho, T. C., Makriyannis, A., & Desai, R. I. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109646 · Cited by 6
Blocking of opioid receptors in experimental formaline-inactivated respiratory syncytial virus (FI-RSV) immunopathogenesis: from beneficial to harmful impacts
Salimi, V., Mirzaei, H., Ramezani, A., Tahamtan, A., Jamali, A., Shahabi, S., Golaram, M., Minaei, B., Gharagozlou, M. J., Mahmoodi, M., et al. (2017) · Medical Microbiology and Immunology · doi:10.1007/s00430-017-0531-0 · Cited by 6
UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co‐morbid sleep impairment
Datta, I., Erridge, S., Holvey, C., Coomber, R., Guru, R., Holden, W., Medniuk, A. D., Sajad, M., Searle, R. D., Usmani, A., et al. (2024) · Pain Practice · doi:10.1111/papr.13438 · Cited by 5
Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
Hasbi, A., & George, S. R. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.100498 · Cited by 5
Cannabinoid CB1 receptor and mu-opioid receptor interaction: new insights from conditional knockout mice
Alton, H., Linz, E., Bi, G., Soler‐Cedeño, O., Maras, M., & Xi, Z. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02245-6 · Cited by 5
Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy
Farkas, D. J., Cooper, Z. D., Heydari, L. N., Hughes, A. C., Rawls, S. M., & Ward, S. J. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0064 · Cited by 5
Syndrome de sevrage au cannabis dans une population de patients mono- et polydépendants (cannabis et opiacés)
Vorspan, F., Guillem, E., Bloch, V., Bellais, L., Sicot, R., Noble, F., Lépine, J., & Gorelick, D. A. (2011) · L Encéphale · doi:10.1016/j.encep.2010.12.007 · Cited by 5
Neuropeptide Receptors
Jr.Devi, G. (2013) · Colloquium Series on Neuropeptides · doi:10.4199/c00082ed1v01y201304npe004 · Cited by 5
Protein-protein allosteric effects on cannabinoid receptor heteromer signaling
Young, A. P., Adderley, S. J., Bagher, A. M., & Denovan‐Wright, E. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819771-4.00001-4 · Cited by 5
Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo
Liu, W. M., Hall, N., Liu, H., Hood, F., & Dalgleish, A. G. (2022) · Oncology Reports · doi:10.3892/or.2022.8287 · Cited by 5
Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB1 receptors
Takemura, Y., Sudo, Y., Saeki, T., Kurata, S., Suzuki, T., Mori, T., & Uezono, Y. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.04.002 · Cited by 5
Regulation of Cannabinoid and Opioid Receptor Levels by Endogenous and Pharmacological Chaperones
Gupta, A., Gomes, I., Osman, A., Fujita, W., & Devi, L. A. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002187 · Cited by 5
Self-citation
BRAIN-DERIVED NEUROTROPHIC FACTOR AND ENDOCANNABINOID FUNCTIONS IN GABAERGIC INTERNEURON DEVELOPMENT
Berghuis, P. (2007) · Figshare · Cited by 5
UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Cancer Pain
Varadpande, M., Erridge, S., Aggarwal, A., Cowley, I., Evans, L., Clarke, E., McLachlan, K., Coomber, R., Rucker, J., Platt, M. W., et al. (2025) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2025.2457101 · Cited by 4
Cannabinoid Receptor 1 associates to different molecular complexes during GABAergic neuron maturation
Molina‐Holgado, E., Paniagua‐Torija, B., Arévalo‐Martín, Á., Moreno‐Luna, R., Esteban, P. F., Le, M. Q. U., Cerro, M. D., & García‐Ovejero, D. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15381 · Cited by 4
The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes
Kracke, G. R., Stoneking, S. P., Ball, J. M., Tilghman, B. M., Washington, C. C., Hotaling, K. A., Johnson, J. O., & Tobias, J. D. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0201-7 · Cited by 4
The Role of the Endocannabinoid System in Addiction
Trigo, J. M., & Foll, B. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809666-6.00006-x · Cited by 4
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data
Coschi, C. H., Ding, K., Tong, J., Tu, D., O’Callaghan, C., Leighl, N. B., Vera-Badillo, F., Juergens, R. A., Hao, D., Seymour, L., et al. (2025) · Immunotherapy · doi:10.1080/1750743x.2025.2485012 · Cited by 5
Cannabinoid-Opioid Interactions
Miller, M. L., Chadwick, B. J., Morris, C. V., Michaelides, M., & Hurd, Y. L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_15 · Cited by 3
Drug interactions with Cannabis sativa: Mechanisms and clinical implication
Hasanpoor, A., Akaberi, M., Kesharwani, P., Sobhani, Z., & Sahebkar, A. (2023) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2023.10.004 · Cited by 3
Adjuvant non-opioid analgesics decrease in-hospital mortality in targeted patients with acute pancreatitis receiving opioids
Zeng, J., He, H., Song, Y., Wei, W., Han, Y., Su, X., Lyu, W., Zhao, J., Han, L., Wu, Z., et al. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002868 · Cited by 3
Comparison and interaction of morphine and CB1 agonist conditioned place preference in the rat model of early life stress
Pirri, F., Akbarabadi, A., Sadat‐Shirazi, M., Zadeh‐Tehrani, S. N., Mahboubi, S., Goudarzi, A. K., & Zarrindast, M. (2021) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10094 · Cited by 3
Monitoring Opioid Receptor Interaction in Living Cells by Bioluminescence Resonance Energy Transfer (BRET)
Baiula, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0884-5_4 · Cited by 3
Class A GPCRs: Cannabinoid and Opioid Receptor Heteromers
Sierra, S., Gomes, I., & Devi, L. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-60174-8_7 · Cited by 3
Self-citation
Neurobiological effects of early life cannabis exposure in relation to the gateway hypothesis
Ellgren, M. (2007) · Figshare · Cited by 3
Neurobiology of opioid use disorder
Cucinello‐Ragland, J. A., Lintz, T., & Morón, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26504-4.00008-9 · Cited by 2
Mechanism of μ-opioid receptor inhibition by orphan GPR88
del Torrent, C. L., Raïch, I., Carrasco-Martinez, B., Lillo, J., Gallo, M., Andreu, D., Pardo, L., & Navarro, G. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2025.108084 · Cited by 2
Functional activity of the cannabinoid 1 receptor is not affected by opioid antagonists in the rat brain
Lee, H. (2013) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2013.64.3.257 · Cited by 2
Monitoring Opioid Receptor Dimerization in Living Cells by Bioluminescence Resonance Energy Transfer (BRET)
Baiula, M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1708-2_8 · Cited by 2
Design and synthesis of unique morphinan-type molecules: Their application to the search for the unexplored binding domain between opioid receptors and morphinan ligands
Maeda, K., Sugai, T., Tokuda, A., Kajino, K., Saitoh, T., Nagase, H., & Kutsumura, N. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129611 · Cited by 2
Elevating Endogenous Cannabinoids Reduces Opioid Withdrawal in Mice
Ramesh, D. (2012) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/xdwb-4257 · Cited by 2
Further Characterization of a Novel Tetrapeptide with an Analgesic Action in the Central and Peripheral Nervous System in Rats
Skubatz, H., & Klatt, B. (2011) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-011-9277-5 · Cited by 2
Functional Selectivity at Receptors for Cannabinoids and Other Lipids
Howlett, A. C. (2009) · The Receptors · doi:10.1007/978-1-60327-335-0_11 · Cited by 2
Cannabinoid-Based Medicine: Pharmacology and Drug Interactions
Davis, M. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-89918-9_2 · Cited by 2
Genetic Studies of Opioid System Function in Mice
Ansonoff, M. A., Wen, T., & Pintar, J. E. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_13 · Cited by 1
New approaches for G-protein coupled receptor ligands identification
Heimann, A. S., & Ferro, E. S. (2009) · Annual Review of Biomedical Sciences · doi:10.5016/1806-8774.2009v11pt95 · Cited by 1
A maconha aumenta vulnerabilidade a opioides em animais de laboratório
de Carvalho, C. R., & Takahashi, R. N. (2014) · Revista da Biologia · doi:10.7594/revbio.13.01.02 · Cited by 2
Cannabinoid Modulation of Dopaminergic Circuits in Neurodegenerative and Neuropsychiatric Disorders
Matricon, J., & Giuffrida, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_5 · Cited by 1
Novel Mechanisms of G Protein-Coupled Receptor Oligomer and Ion Channel Interactions in Nociception
Yekkirala, A. S. (2013) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-779-2_19 · Cited by 1
Therapeutic cannabis: what clinicians need to know ... and other fun facts
Leach, S. L. (2017) · Cited by 1
GPCR Heterodimers: Implications for Biased Signaling
Li, L., Li, Y., Zhang, S., Shen, C., Meng, J., & Liu, J. (2025) · Handbook of experimental pharmacology · doi:10.1007/164_2025_762 · Cited by 1
No pain, no gain: balancing central versus peripheral benefits of analgesics in the age of the opioid crisis
Patel, H. H., & Roth, D. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14130 · Cited by 1
Interactive effects of (±)-trans-U50488 and its stereoisomers with cannabinoids
Erwin, L. L., Nilges, M. R., Denys, I. B., Sutphen, J. C., Friend, A. J., Kapusta, D. R., & Winsauer, P. J. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173218 · Cited by 1
Secretin Receptor Dimerization: A Possible Functionally Important Paradigm for Family B G Protein‐Coupled Receptors
Harikumar, K. G., Dong, M., & Miller, L. J. (2010) · Wiley eBooks · doi:10.1002/9780470627327.ch6 · Cited by 1
Agonist-dependent mechanism of mu-opioid receptor desensitization
Chu, J. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)
Factors Influencing Opioid Receptor Signaling to Adenylyl Cyclase.
Levitt, E. S. (2010) · Deep Blue (University of Michigan)
The N-t erminus of the Saccharomyces cerevisiae G protein-coupled receptor Ste2p: formation of dimer interfaces and negative regulation
Uddin, M. S. (2013)
Die funktionelle Relevanz von Oligomerisierung in vitro und in vivo am Beispiel von G-Protein-gekoppelten Rezeptoren in der hypothalamischen Gewichtsregulation
Piechowski, C. L. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6289
Ultra-Low Dose Antagonist Effects on Cannabinoids and Opioids in Models of Pain: Is Less More?
Paquette, J. J. (2007)
Participação do sistema canabinoide em processos oxidativo e inflamatório relacionados à neurodegeneração in vitro
Humana, F. (2014)
revisit in 2012 Physiology of the orexinergic/hypocretinergic system: a
Kukkonen, J. P. (2013)
Functional Role(s) of Dimeric Complexes Formed from G-Protein-Coupled Receptors
Rozenfeld, R., & Devi, L. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00028-0
Self-citation
Incorporation of unnatural amino acid for the tagging of cannabinoid receptors 1 and 2 reveals receptor roles in regulating cAMP levelsPreprint
Thomas, A., Schultz, C., & Laguerre, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.09.447758
Неканоническая активность эндоканнабиноидов и их рецепторов в центральных и периферических синапсах
Balezina, O. P., Tarasova, E. O., & Гайдуков, А. Е. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521070010
Cannabis
Streel, E., & Chinet, L. (2008) · Carrefour des psychothérapies · doi:10.3917/dbu.stree.2008.01.0161
Therapeutic Management with Repurposing Approaches: A Mystery During COVID-19 Outbreak
Chaudhury, S., Kaur, P., Gupta, D., Anand, P., Chaudhary, M., Tiwari, S., Mittal, A., Gupta, J., Kaur, S., Singh, V. D., et al. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230613141746

Authors: Rios, C., Gomes, I., & Devi, L. A.
Affiliations: Cornell University (US)
Icahn School of Medicine at Mount Sinai (US)
Corresponding author: Devi, Lakshmi A
ORCID: Gomes, Ivone
Devi, Lakshmi A
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2006-06
Volume: 148
Issue: 4
Pages: 387-395
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1038/sj.bjp.0706757
PMC: PMC1751792
OpenAlex: W1487872499
Cited by: 327
References: 42
Citations by year: 2026: 7 · 2025: 14 · 2024: 13 · 2023: 7 · 2022: 10 · 2021: 16 · 2020: 17 · 2019: 15 · 2018: 11 · 2017: 15 · 2016: 16 · 2015: 9 · 2014: 18 · 2013: 21 · 2012: 25
FWCI: 14.41
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 973 d)
Locations: British Journal of Pharmacology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (DA08863)
National Institute on Drug Abuse (DA 08863, K05DA019521, R56DA008863, R37DA008863, DA19521, R01DA008863)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: mu-opioid receptor, CB1 receptor, receptor-receptor interactions, opioid-cannabinoid interaction, neurite outgrowth, bioluminescence resonance energy transfer, CCR5 chemokine receptor, MAPK phosphorylation, Src phosphorylation, STAT3 phosphorylation, N2a cells
MeSH terms: Cells, Cultured, Humans, Phosphorylation, Signal Transduction, Guanosine 5'-O-(3-Thiotriphosphate), Neurites, Receptors, Opioid, mu, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Receptor, Cannabinoid, CB1, Extracellular Signal-Regulated MAP Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks